Q32 Bio (QTTB) Return on Equity (2018 - 2025)
Historic Return on Equity for Q32 Bio (QTTB) over the last 8 years, with Q3 2025 value amounting to 2.74%.
- Q32 Bio's Return on Equity rose 50300.0% to 2.74% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.74%, marking a year-over-year increase of 50300.0%. This contributed to the annual value of 0.52% for FY2024, which is 212200.0% down from last year.
- According to the latest figures from Q3 2025, Q32 Bio's Return on Equity is 2.74%, which was up 50300.0% from 6.44% recorded in Q2 2025.
- Q32 Bio's Return on Equity's 5-year high stood at 6.44% during Q2 2025, with a 5-year trough of 70.25% in Q1 2025.
- Its 5-year average for Return on Equity is 3.86%, with a median of 0.01% in 2022.
- Over the last 5 years, Q32 Bio's Return on Equity had its largest YoY gain of 77800bps in 2025, and its largest YoY loss of -709300bps in 2025.
- Quarter analysis of 5 years shows Q32 Bio's Return on Equity stood at 0.52% in 2021, then soared by 99bps to 0.01% in 2022, then skyrocketed by 4230bps to 0.32% in 2023, then plummeted by -1315bps to 3.85% in 2024, then skyrocketed by 171bps to 2.74% in 2025.
- Its Return on Equity was 2.74% in Q3 2025, compared to 6.44% in Q2 2025 and 70.25% in Q1 2025.